Albany, NY -- (SBWire) -- 12/03/2014 --Research on China Monoclonal Antibody (McAB) Industry, 2014 mainly carries on in-depth analysis on policy environment, global market, Chinese market, as well as the latest developments of domestic key enterprises related to China's monoclonal antibody industry.
View Full Report at http://www.marketresearchreports.biz/analysis/219173
Several Chinese large-scale pharmaceutical enterprises devoted themselves to research and development of monoclonal antibody agents, which have achieved results in 2013. Hengrui Medicine Co., Ltd., Shanghai Pharmaceuticals Co., Ltd. and Qilu Pharm have applied for clinical research of monoclonal antibody agents. And Walvax Biotechnology Co., Ltd even made a huge investment in purchasing Genor Biopharma Co., Ltd, attempting to establish a large biological strategy. Although large-scale pharmaceutical enterprises entered monoclonal antibody field on a large scale, the overall innovation is still insufficient, and the market is represented by monoclonal antibody agents and biological analogue that have submitted applications, few imitated drugs, and innovative medicines are rare and precious things, mainly on account of high risks and long-time cycle.
Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/219173
Due to late state, China's strength on research and development will be still vulnerable within future three to five years, so it has to open the market preliminarily by depending on generic drugs. In 2013, the market size was CNY 3.8 billion around, up 30% year-on-year; product categories and sales volume were far less than that of European and American countries.
Explore All Latest Published Reports By Huidian Research at http://www.marketresearchreports.biz/publisher/81
According to statistical data of Shanghai Pharmaceutical Profession Association (SPPA), China will see four to six monoclonal antibody agents by 2016, such as Trastuzumab and Rituximab. And it is expected by 2020, six to ten monoclonal antibody agents will be listed in market, and some of which are independently researched drugs. Huidian Research believes that China's monoclonal antibody market will embrace its first climax from 2017 to 2020.
Related Reports
Male Infertility Global Clinical Trials Review, H2, 2014
View Full Report at http://www.marketresearchreports.biz/analysis/233310
GlobalData's clinical trial report, Male Infertility Global Clinical Trials Review, H2, 2014" provides data on the Male Infertility clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Male Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/233310
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Male Infertility. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Women Infertility Global Clinical Trials Review, H2, 2014
View Full Report at http://www.marketresearchreports.biz/analysis/233311
GlobalData's clinical trial report, Women Infertility Global Clinical Trials Review, H2, 2014" provides data on the Women Infertility clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Women Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/233311
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Women Infertility. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Browse Blog at https://chinaindustryanalysis.wordpress.com
Research on China Monoclonal Antibody (McAB) Industry, 2014
The Report Research on China Monoclonal Antibody (McAB) Industry, 2014 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz